Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Journal of Medicinal Chemistry
|
June 23, 1995
[(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinase
P Traxler, U Trinks, E Buchdunger, et al.
International Journal of Cancer
|
May 21, 1999
Author errata
N Lydon, H Mett, M Mueller, et al.
Cancer Research
|
September 1, 1992
New S-adenosylmethionine decarboxylase inhibitors with potent antitumor activity
U Regenass, G Caravatti, H Mett, et al.
Journal of Medicinal Chemistry
|
April 1, 1994
Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase
U Trinks, E Buchdunger, P Furet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 1995
4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity
E Buchdunger, H Mett, U Trinks, et al.
International Journal of Cancer
|
April 9, 1998
A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo
N B Lydon, H Mett, M Mueller, et al.
Journal of Medicinal Chemistry
|
November 14, 1997
Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines
P Traxler, G Bold, J Frei, et al.
The Biochemical Journal
|
November 1, 1992
Purification and biochemical characterization of non-myristoylated recombinant pp60c-src kinase
N B Lydon, B Gay, H Mett, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 1994
4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity
E Buchdunger, U Trinks, H Mett, et al.
European Journal of Biochemistry
|
November 15, 1995
Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2
F Meggio, A Donella Deana, M Ruzzene, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Journal of Medicinal Chemistry
|
June 23, 1995
[(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinase
P Traxler, U Trinks, E Buchdunger, et al.
International Journal of Cancer
|
May 21, 1999
Author errata
N Lydon, H Mett, M Mueller, et al.
Cancer Research
|
September 1, 1992
New S-adenosylmethionine decarboxylase inhibitors with potent antitumor activity
U Regenass, G Caravatti, H Mett, et al.
Journal of Medicinal Chemistry
|
April 1, 1994
Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase
U Trinks, E Buchdunger, P Furet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 1995
4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity
E Buchdunger, H Mett, U Trinks, et al.
International Journal of Cancer
|
April 9, 1998
A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo
N B Lydon, H Mett, M Mueller, et al.
Journal of Medicinal Chemistry
|
November 14, 1997
Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines
P Traxler, G Bold, J Frei, et al.
The Biochemical Journal
|
November 1, 1992
Purification and biochemical characterization of non-myristoylated recombinant pp60c-src kinase
N B Lydon, B Gay, H Mett, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 1994
4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity
E Buchdunger, U Trinks, H Mett, et al.
European Journal of Biochemistry
|
November 15, 1995
Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2
F Meggio, A Donella Deana, M Ruzzene, et al.
Page
of 6